Anna Casabianca
Impact in
- Virology top 1%
- HIV Research and Treatment
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
- Virology 38
- HIV Research and Treatment 38
-
- HIV/AIDS drug development and treatment 25
- HIV/AIDS Research and Interventions 11
- SARS-CoV-2 and COVID-19 Research 5
- Co-authors
- Mauro MagnaniAlessandra FraternaleChiara OrlandiGiorgio BrandiLaura ChiarantiniMaria Filomena PaolettiEnrico GaraciAntonella Penna
- Journals
- JAIDS Journal of Acquired Immune Deficiency Syndromes (4 papers)Antiviral Research (4 papers)PLoS ONE (4 papers)Biochemical Journal (3 papers)Antiviral chemistry & chemotherapy (3 papers)
- Partner nations
- ItalyUnited StatesFrance
In The Last Decade
Anna Casabianca
61 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 100
- Virology 436
- Infectious Diseases 375
- Environmental Chemistry 159
- Immunology 275
- Biochemistry 92
Countries citing papers authored by Anna Casabianca
This map shows the geographic impact of Anna Casabianca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Casabianca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Casabianca more than expected).
Fields of papers citing papers by Anna Casabianca
This network shows the impact of papers produced by Anna Casabianca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Casabianca. The network helps show where Anna Casabianca may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Anna Casabianca, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 9 | |
| 2 | 2023 | 2 | |
| 3 | 2022 | 6 | |
| 4 | 2022 | 4 | |
| 5 | 2020 | 7 | |
| 6 | 2019 | 4 | |
| 7 | 2018 | 8 | |
| 8 | 2014 | 20 | |
| 9 | 2014 | 28 | |
| 10 | 2013 | 27 | |
| 11 | 2011 | 73 | |
| 12 | 2009 | 10 | |
| 13 | 2008 | 121 | |
| 14 | 2007 | 30 | |
| 15 | 2006 | 49 | |
| 16 | 2000 | 8 | |
| 17 | 2000 | 7 | |
| 18 | Role of macrophage protection in the development of murine AIDS. | 1999 | 14 |
| 19 | 1997 | 4 | |
| 20 | 1992 | 6 |
About Anna Casabianca
Anna Casabianca is a scholar working on Virology, Infectious Diseases, Biochemistry, Immunology and Clinical Biochemistry, having authored 63 papers that have together received 1.3k indexed citations. Recurring topics across this work include HIV Research and Treatment (38 papers), HIV/AIDS drug development and treatment (25 papers), Immune Cell Function and Interaction (12 papers), HIV/AIDS Research and Interventions (11 papers), Cytomegalovirus and herpesvirus research (10 papers), SARS-CoV-2 and COVID-19 Research (5 papers), Marine Toxins and Detection Methods (5 papers) and Metabolism and Genetic Disorders (4 papers). The work is most often cited by research in Virology (436 citations), Infectious Diseases (375 citations), Environmental Chemistry (159 citations), Immunology (275 citations) and Biochemistry (92 citations). Anna Casabianca has collaborated with scholars based in Italy, United States and France. Frequent co-authors include Mauro Magnani, Alessandra Fraternale, Chiara Orlandi, Giorgio Brandi, Laura Chiarantini, Maria Filomena Paoletti, Enrico Garaci, Antonella Penna, Anna Teresa Palamara and Carlo Federico Perno. Their work appears in journals such as JAIDS Journal of Acquired Immune Deficiency Syndromes, Antiviral Research, PLoS ONE, Biochemical Journal and Antiviral chemistry & chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.